Inhibition of ERRα Prevents Mitochondrial Pyruvate Uptake Exposing NADPH-Generating Pathwaysas Targetable Vulnerabilities in Breast Cancer

od Park, Sunghee, Safi, Rachid, Liu, Xiaojing, Baldi, Robert, Liu, Wen, Liu, Juan, Locasale, Jason W., Chang, Ching-yi, McDonnell, Donald P.
izdano v Cell Rep (2019)

Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease

od Crook, Kristen R., Jin, Mengyao, Weeks, Michael F., Rampersad, Rishi R., Baldi, Robert M., Glekas, Amy S., Shen, Yajuan, Esserman, Denise A., Little, Paul, Schwartz, Todd A., Liu, Peng
izdano v J Leukoc Biol (2015)

ERRα Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer

od Park, Sunghee, Chang, Ching-yi, Safi, Rachid, Liu, Xiaojing, Baldi, Robert, Jasper, Jeff S., Anderson, Grace R., Liu, Tingyu, Rathmell, Jeffrey C., Dewhirst, Mark W., Wood, Kris C., Locasale, Jason W., McDonnell, Donald P.
izdano v Cell Rep (2016)

Metabolic Control Analysis Uncovers a Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product

od Liberti, Maria V., Dai, Ziwei, Wardell, Suzanne E., Baccile, Joshua A., Liu, Xiaojing, Gao, Xia, Baldi, Robert, Mehrmohamadi, Mahya, Johnson, Marc O., Madhukar, Neel S., Shestov, Alexander A., Christine Chio, Iok I., Elemento, Olivier, Rathmell, Jeffrey C., Schroeder, Frank C., McDonnell, Donald P., Locasale, Jason W.
izdano v Cell Metab (2017)

Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer

od Norris, John D., Ellison, Stephanie J., Baker, Jennifer G., Stagg, David B., Wardell, Suzanne E., Park, Sunghee, Alley, Holly M., Baldi, Robert M., Yllanes, Alexander, Andreano, Kaitlyn J., Stice, James P., Lawrence, Scott A., Eisner, Joel R., Price, Douglas K., Moore, William R., Figg, William D., McDonnell, Donald P.
izdano v J Clin Invest (2017)

G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer

od Andreano, Kaitlyn J., Wardell, Suzanne E., Baker, Jennifer G., Desautels, Taylor K., Baldi, Robert, Chao, Christina A., Heetderks, Kendall A., Bae, Yeeun, Xiong, Rui, Tonetti, Debra A., Gutgesell, Lauren M., Zhao, Jiong, Sorrentino, Jessica A., Thompson, Delita A., Bisi, John E., Strum, Jay C., Thatcher, Gregory R. J., Norris, John D.
izdano v Breast Cancer Res Treat (2020)

The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer

od Cocce, Kimberly J., Jasper, Jeff S., Desautels, Taylor K., Everett, Logan, Wardell, Suzanne, Westerling, Thomas, Baldi, Robert, Wright, Tricia M., Tavares, Kendall, Yllanes, Alex, Bae, Yeeun, Blitzer, Jeremy T., Logsdon, Craig, Rakiec, Daniel P., Ruddy, David A., Jiang, Tiancong, Broadwater, Gloria, Hyslop, Terry, Hall, Allison, Laine, Muriel, Phung, Linda, Greene, Geoffrey L., Martin, Lesley-Ann, Pancholi, Sunil, Dowsett, Mitch, Detre, Simone, Marks, Jeffrey R., Crawford, Gregory E., Brown, Myles, Norris, John D., Chang, Ching-yi, McDonnell, Donald P.
izdano v Cell Rep (2019)